One such target is the enzyme NUDT5 (also known as NUDIX5, Nudix-linked to moiety X-5), which we have shown to be essential for HR+ breast cancer growth and breast cancer stem cell (BCSC) initiation and maintenance [24,25]. This evidence concerns the gene NUDT5 and breast carcinoma.